Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma
Elevated serum levels of cystatin C are found to be related to poor outcome and metastatic potential of some malignant disorders. To evaluate the clinical prominence of serum cystatin C in diffuse large B-cell lymphoma (DLBCL), blood samples were obtained from 58 patients at the time of diagnosis an...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Österreichische Apotheker-Verlagsgesellschaft m. b. H.
2017-03-01
|
Series: | Scientia Pharmaceutica |
Subjects: | |
Online Access: | http://www.mdpi.com/2218-0532/85/1/9 |